X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (161) 161
humans (152) 152
severe osteogenesis imperfecta (119) 119
child (65) 65
female (62) 62
children (48) 48
male (48) 48
animals (46) 46
adolescent (43) 43
pediatrics (43) 43
osteoporosis (42) 42
diphosphonates - therapeutic use (37) 37
severe combined immunodeficiency (36) 36
stem cells (34) 34
child, preschool (32) 32
endocrinology & metabolism (31) 31
osteogenesis imperfecta (31) 31
bisphosphonates (27) 27
pamidronate (27) 27
transplantation (25) 25
bone-mineral density (24) 24
marrow stromal cells (24) 24
intravenous pamidronate (22) 22
pregnancy (22) 22
bone density (21) 21
bone density - drug effects (20) 20
infant (20) 20
osteoporosis - drug therapy (19) 19
bone density conservation agents - therapeutic use (18) 18
cell biology (18) 18
diphosphonates - adverse effects (18) 18
in-utero transplantation (18) 18
mesenchymal stromal cells - cytology (18) 18
therapy (18) 18
treatment outcome (18) 18
abridged index medicus (17) 17
fractures (17) 17
in-vitro (17) 17
orthopedics (17) 17
radiography (17) 17
bone (16) 16
diphosphonates - administration & dosage (16) 16
gene therapy (16) 16
medicine, research & experimental (16) 16
progenitor cells (16) 16
adult (15) 15
biotechnology & applied microbiology (15) 15
bisphosphonate (15) 15
fibrous dysplasia (15) 15
hematology (15) 15
intravenous pamidronate treatment (15) 15
obstetrics & gynecology (15) 15
rheumatology (15) 15
adolescents (14) 14
alendronate (14) 14
mesenchymal stem cells (14) 14
osteogenesis imperfecta - drug therapy (14) 14
pamidronate treatment (14) 14
article (13) 13
bone-marrow-transplantation (13) 13
mutation (13) 13
umbilical-cord blood (13) 13
analysis (12) 12
bone-marrow (12) 12
cell & tissue engineering (12) 12
genetics & heredity (12) 12
mesenchymal stem cell transplantation (12) 12
mice (12) 12
stem cell transplantation (12) 12
stromal cells (12) 12
tissue engineering (12) 12
diphosphonates - pharmacology (11) 11
infant, newborn (11) 11
medicine & public health (11) 11
absorptiometry, photon (10) 10
bone marrow (10) 10
bone mineral density (10) 10
bones (10) 10
genetic therapy (10) 10
genetic therapy - methods (10) 10
health aspects (10) 10
hematopoietic stem cells (10) 10
mesenchymal stromal cells - physiology (10) 10
oncology (10) 10
surgery (10) 10
versus-host-disease (10) 10
cell differentiation (9) 9
density (9) 9
glucocorticoid-induced osteoporosis (9) 9
human bone-marrow (9) 9
mesenchymal stem cell transplantation - methods (9) 9
stem cell (9) 9
x-ray absorptiometry (9) 9
acute lymphoblastic-leukemia (8) 8
bisphosphonate therapy (8) 8
bone density conservation agents - adverse effects (8) 8
cells, cultured (8) 8
fetal diseases - therapy (8) 8
growth (8) 8
medicine (8) 8
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Credit Valley Hospital - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CANCER RADIOTHERAPIE, ISSN 1278-3218, 03/2014, Volume 18, Issue 2, pp. 132 - 135
Osteogenesis imperfecta is an unusual disease also called Lobstein disease. Characterized by abnormalities of collagen biosynthesis, a possible mutation on... 
Chemotherapy | ONCOLOGY | Osteogenesis imperfecta | OSTEOSARCOMA | Radiation therapy | Lobstein disease | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SEVERE 5-FLUOROURACIL TOXICITY | Breast neoplasm
Journal Article
Journal of Pediatric Endocrinology and Metabolism, ISSN 0334-018X, 2008, Volume 21, Issue 1, pp. 63 - 72
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 02/2009, Volume 94, Issue 2, pp. 400 - 409
Context: As awareness of osteoporosis in childhood has increased, so have pressures to consider use of the pharmacological agents used to treat osteoporosis in... 
PAMIDRONATE TREATMENT | ANOREXIA-NERVOSA | INTRAVENOUS ZOLEDRONIC ACID | BONE-MINERAL DENSITY | BIOCHEMICAL MARKERS | SEVERE OSTEOGENESIS IMPERFECTA | ENDOCRINOLOGY & METABOLISM | ORAL ALENDRONATE | PLACEBO-CONTROLLED TRIAL | CEREBRAL-PALSY | TREAT OSTEOPENIA
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 12/2015, Volume 173, Issue 6, pp. R185 - R197
Journal Article
Osteoporosis International, ISSN 0937-941X, 11/2012, Volume 23, Issue 11, pp. 2703 - 2711
The impact of intravenous bisphosphonate treatment to treat painful vertebral fractures in boys with DMD has not been documented. In this retrospective... 
Bone histomorphometry | Vertebral fractures | Corticosteroid osteoporosis | Medicine & Public Health | Gynecology | Orthopedics | Rheumatology | Clinical/pediatrics | Bone mineral density | Bisphosphonates | Endocrinology | PAMIDRONATE TREATMENT | TURNOVER | BONE-MINERAL DENSITY | SEVERE OSTEOGENESIS IMPERFECTA | PUBERTAL CHANGES | RHEUMATIC DISORDERS | PEDIATRIC POPULATION | CHILDREN | ACUTE LYMPHOBLASTIC-LEUKEMIA | ENDOCRINOLOGY & METABOLISM | DEFLAZACORT | Drug Evaluation - methods | Back Pain - physiopathology | Humans | Spinal Fractures - etiology | Male | Osteoporosis - drug therapy | Osteoporotic Fractures - drug therapy | Back Pain - drug therapy | Osteoporotic Fractures - etiology | Spinal Fractures - drug therapy | Diphosphonates - therapeutic use | Retrospective Studies | Osteoporotic Fractures - physiopathology | Child | Diphosphonates - adverse effects | Osteoporosis - physiopathology | Glucocorticoids - adverse effects | Back Pain - etiology | Bone Density Conservation Agents - adverse effects | Muscular Dystrophy, Duchenne - drug therapy | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Muscular Dystrophy, Duchenne - complications | Spinal Fractures - physiopathology | Bone Density - drug effects | Osteoporosis - pathology | Biopsy | Adolescent | Ilium - pathology | Infusions, Intravenous | Pediatrics | Fractures | Drug therapy | Spine | Muscular dystrophy | Vertebrae | Intravenous administration | Fever | Osteoporosis | Side effects | Pain | Vomiting | Duchenne's muscular dystrophy | Risk assessment | Zoledronic acid | Standard deviation | Osteomalacia | Hypocalcemia | Osteogenesis | Index Medicus
Journal Article
Osteoporosis International, ISSN 0937-941X, 2/2017, Volume 28, Issue 2, pp. 597 - 608
Boys with vertebral fractures (VF) identified through routine spine radiographs had milder, less symptomatic, and fewer VF compared to those diagnosed with VF... 
Osteoporosis | Medicine & Public Health | Glucocorticoids | Orthopedics | Duchenne muscular dystrophy | Rheumatology | First fractures | Endocrinology | RISK-FACTORS | BONE-MINERAL DENSITY | SEVERE OSTEOGENESIS IMPERFECTA | RHEUMATIC DISORDERS | INCIDENT VERTEBRAL FRACTURES | INTRAVENOUS BISPHOSPHONATE THERAPY | GLUCOCORTICOID INITIATION | PEDIATRIC OSTEOPOROSIS | ENDOCRINOLOGY & METABOLISM | X-RAY ABSORPTIOMETRY | CORTICOSTEROID TREATMENT | Thoracic Vertebrae - physiopathology | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Bone Density - physiology | Humans | Osteoporotic Fractures - diagnostic imaging | Spinal Fractures - etiology | Child, Preschool | Male | Osteoporotic Fractures - etiology | Time Factors | Muscular Dystrophy, Duchenne - physiopathology | Retrospective Studies | Osteoporotic Fractures - physiopathology | Child | Glucocorticoids - adverse effects | Lumbar Vertebrae - physiopathology | Thoracic Vertebrae - diagnostic imaging | Drug Administration Schedule | Lumbar Vertebrae - diagnostic imaging | Muscular Dystrophy, Duchenne - complications | Spinal Fractures - physiopathology | Spinal Fractures - diagnostic imaging | Radiography | Adolescent | Longitudinal Studies | Complications and side effects | Fractures | Research | Risk factors | Back pain | Vertebrae | Spine (lumbar) | Muscular dystrophy | Pain | Duchenne's muscular dystrophy | Bone mineral density | Bone (long) | Dystrophy | Diagnosis | Index Medicus
Journal Article
Journal Article
The Journal of Bone & Joint Surgery, ISSN 0021-9355, 07/2007, Volume 89, Issue 7, pp. 1511 - 1516
BackgroundPamidronate therapy is increasingly used in children for the treatment of low bone mineral density and increased bone fragility resulting from a... 
TRIAL | SURGERY | SEVERE OSTEOGENESIS IMPERFECTA | GROWTH | ARREST LINES | INTRAVENOUS PAMIDRONATE | BISPHOSPHONATE TREATMENT | BONE | FIBROUS DYSPLASIA | ORTHOPEDICS | OSTEOPOROSIS | ALENDRONATE
Journal Article